Medical expulsive therapy for ureteric stones: Analysing the evidence from systematic reviews and meta-analysis of powered double-blinded randomised controlled trials
- PMID: 29071136
- PMCID: PMC5653615
- DOI: 10.1016/j.aju.2017.03.005
Medical expulsive therapy for ureteric stones: Analysing the evidence from systematic reviews and meta-analysis of powered double-blinded randomised controlled trials
Abstract
Objective: To conduct a systematic review and meta-analysis investigating the efficacy and safety of medical expulsive therapy (MET) in low risk of bias (RoB) randomised controlled trials (RCTs).
Methods: A Cochrane style systematic review was conducted on published literature from 1990 to 2016, to include low RoB and a power calculation. A pooled meta-analysis was conducted.
Results: The MET group included 1387 vs 1381 patients in the control group. The analysis reveals α-blockers increased stone expulsion rates (78% vs 74%) (P < 0.001), whilst calcium channel blockers (CCBs) had no effect compared to controls (79% vs 75%) (P = 0.38). In the subgroup analysis, α-blockers had a shorter time to stone expulsion vs the control group (P < 0.001). There were no significant differences in expulsion rates between the treatment groups and control group for stones <5 mm in size (P = 0.48), proximal or mid-ureteric stones (P = 0.63 and P = 0.22, respectively). However, α-blockers increased stone expulsion in stones >5 mm (P = 0.02), as well as distal ureteric stones (P < 0.001). The α-blocker group developed more side-effects (6.6% of patients; P < 0.001). The numbers needed to treat for α-blockers was one in 14, for stones >5 mm one in eight, and for distal stones one in 10.
Conclusion: The primary findings show a small overall benefit for α-blockers as MET for ureteric stones but no benefit with CCBs. α-blockers show a greater benefit for large (>5 mm) ureteric stones and those located in the distal ureter, but no benefit for smaller or more proximal stones. α-blockers are associated with a greater risk of side-effects compared to placebo or CCBs.
Keywords: ARR, absolute risk reduction; CCB, calcium channel blocker; Calcium channel blockers; MD, mean difference; MET, medical expulsive therapy; MeSH, medical subject headings; Medical expulsive therapy (MET); NNT, numbers needed to treat; RCT, randomised controlled trial; RR, risk ratio; RoB, risk of bias; Ureteric stones; Urinary stones; α-Blockers.
Figures
References
-
- Pak C.Y. Kidney stones. Lancet. 1998;351:1797–1801. - PubMed
-
- Ramello A., Vitale C., Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13(Suppl. 3):S45–S50. - PubMed
-
- Ahmad H., Azim W., Akmal M., Murtaza B., Mahmood A., Nadim A. Medical expulsive treatment of distal ureteral stone using tamsulosin. J Ayub Med Coll Abbottabad. 2015;27:48–50. - PubMed
-
- Hollingsworth J.M., Rogers M.A., Kaufman S.R., Bradford T.J., Saint S., Wei J.T. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006;368:1171–1179. - PubMed
-
- Miller O.F., Kane C.J. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol. 1999;162:688–691. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous